Skip to content

Self-management of Post COVID-19 Syndrome Using Wearable Biometric Technology

Self-management of Post COVID-19 Syndrome Using Wearable Biometric Technology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05507190
Enrollment
20
Registered
2022-08-18
Start date
2023-12-01
Completion date
2024-06-30
Last updated
2025-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

Long COVID-19, Persistent symptoms, Self-management

Brief summary

The main objective of this pilot study is to evaluate the impact of a self-management intervention using wearable biometric technology on post-COVID-19 syndrome. In addition, this pilot-study will provide information regarding validity, feasibility, patient compliance and satisfaction, valuable for the design of a future large-scale study.

Detailed description

This pilot-study uses a one-group before-after design. Subjects: a convenience sample of 20 adults 18 years and older in the Winnipeg Health Region with a post-COVID-19 infection (≥ 3 months since acute infection) complaining of mild to severe persistent respiratory symptoms. Intervention: using the participants' initial assessment, personal characteristics, main complaints/needs and goals, the therapist will adjust the exercise plan and personalize the recommendations (e.g. maximum heart rate) as well as instruct the patients about safety precautions (how to pace themselves, when to seek professional or emergency care). Participants will be encouraged to wear the smart shirt as much as they want during the 6 weeks (29), but at a minimum of 1-hour a day (M-F) including while performing the recommended exercises (30-45 min/3 times a week). They should self-monitor their biometric values trying to reach/stay within the target values while wearing the shirt using Hexoskin app installed on an iPad provided by the research team or on the participants' personal device if preferred. Patients will also complete an online survey reporting symptoms intensity and activities completed, 3 times a week (over 6 weeks). Participants would be able to contact the research assistant overseeing the intervention at any time of the study if they have questions or concerns (text message or email). Otherwise, they will receive a follow-up phone call every week or if a significant change in their biometrical data is identified.

Interventions

OTHERSelf-management of post COVID-19 respiratory outcomes

Intervention: using the participants' initial assessment, personal characteristics, main complaints/needs and goals, the therapist will adjust the exercise plan and personalize the recommendations (e.g. maximum heart rate) as well as instruct the patients about safety precautions (how to pace themselves, when to seek professional or emergency care). Participants will be encouraged to wear the smart shirt as much as they want during the 6 weeks (29), but at a minimum of 1-hour a day (M-F) including while performing the recommended exercises (30-45 min/3 times a week). They should self-monitor their biometric values trying to reach/stay within the target values while wearing the shirt using Hexoskin app installed on an iPad provided by the research team or on the participants' personal device if preferred.

Sponsors

University of Manitoba
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Post-COVID-19 ≥ 3 months after infection. * Mild to severe persistent respiratory symptoms * Access to a home internet

Exclusion criteria

* History of neurological disease or mental illness * Inability to ambulate independently without supervision * Inability to complete basic tasks on a smart phone or tablet

Design outcomes

Primary

MeasureTime frameDescription
Exercise capacity6 weeksThe 6-min walk test (6 MWT) and the one-minute sit-to-stand test
Health-related quality of life6 weeksEuroQol five-dimensional questionnaire (0 worse health to 100 best health)
Postural orthostatic hypotension6 weeksOrthostatic Stress Test (Postural transitions)
Change in lung capacity6 weeksIt will be assessed using a SpiroBank Smart F/V multi parameter spirometer (MIR) at pre-post intervention and once a week in between to monitor changes. This portable spirometer, which is MDSAP approved and complaint with ATS/ERS guidelines, connects automatically via Bluetooth to an iOS & Android compatible App (MIR Spirobank). It provides real time feedback through messages and animation on smartphone, to improve personal compliance during the test. The app can generate test results PDF printout with information regarding 19 parameters of lung capacity.
Change in dyspnea6 weeksModified Borg Scale (0 best to 10 worse dyspnea) will be used to assess dyspnea.
Change in fatigue6 weeksFatigue severity scale (0 -7 more fatigue) will be used to measure the severity of fatigue.
Chronic fatigue syndrome6 weeksDePaul Symptoms Questionnaire short form (DSQ-SF) (0 not present - 4 very severe)

Secondary

MeasureTime frameDescription
Patient satisfaction with the study6 weekParticipants will complete a short summary with questions regarding their satisfaction with the study
Symptoms change6 weeksParticipants will be ask to rate their symptoms from 0-10 using an online form (base on the baseline symptoms)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026